Toggle Main Menu Toggle Search

Open Access padlockePrints

Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response

Lookup NU author(s): Professor Heather Cordell, Professor John IsaacsORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


The introduction of tumour necrosis factor antagonists (anti-TNF) has greatly improved the treatment of rheumatoid arthritis, however, a significant proportion of patients fail to respond to therapy. We hypothesized that variants spanning the type 2 TNF receptor (TNFR2) and the TNF cleavage enzyme (TACE) genes contribute towards the observed variation in patient response (defined as the absolute change in 28- joint count disease activity score). Twenty-nine single nucleotide polymorphisms (SNPs) were genotyped in a large cohort of patients (n = 602) and analysed by multivariate linear regression. Three SNPs (rs520916, rs652625, rs597519) mapping upstream of TNFR2 showed borderline evidence for association (P < 0.1) across the complete cohort and, more so, in the etanercept-treated subgroup. However, the evidence of association was neither replicated in an independent cohort (n = 377) nor strengthened after combined analysis (n = 979). We conclude that common SNPs spanning the TNFR2 and TNF cleavage enzyme (TACE) genes do not have a major effect on the response to anti-TNF therapy in rheumatoid arthritis patients. Pharmacogenetics and Genomics 20: 338-341 (c) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Publication metadata

Author(s): Potter C, Gibbons LJ, Bowes JD, Cordell HJ, Hyrich K, Isaacs JD, Morgan AW, Wilson AG, Barton A, Biol Rheumatoid Arthrit Genetics Group

Publication type: Article

Publication status: Published

Journal: Pharmacogenetics and Genomics

Year: 2010

Volume: 20

Issue: 5

Pages: 338-341

Print publication date: 01/05/2010

ISSN (print): 1744-6872

ISSN (electronic): 1744-6880

Publisher: Lippincott Williams & Wilkins


DOI: 10.1097/FPC.0b013e32833878d7


Altmetrics provided by Altmetric


Funder referenceFunder name
NIHR Manchester Biomedical Research Centre
17552Arthritis Research Campaign